Browse the corpus

Patient information: Abdominal hysterectomy (Beyond the Basics) Authors Thomas G Stovall, MD William J Mann, Jr, MD Section Editor Howard T Sharp, MD Deputy Editor Sandy J Falk, MD Find Print ABDOMINAL HYSTERECTOMY OVERVIEW Abdominal hysterectomy is a surgical procedure in which the uterus is removed through an incision in the lower abdomen ( figure 1 ). One or both ovaries and fallopian tubes may also be removed during the procedure ( figure 2 ). FEMALE ANATOMY A brief review of female reproductive anatomy may be of help in understanding hysterectomy. The uterus is a hollow, pear-shaped muscular organ located in the lower abdomen and pelvis ( figure 3 ). At the upper end of the uterus, the fallopian tubes open on each side. The outer end of each tube lays next to an ovary. The ovaries lay next to and slightly behind the uterus. At its lower end, the uterus narrows and opens into the vagina. The lower end of the uterus is called the cervix. REASONS FOR ABDOMINAL HYSTERECTOMY A hysterectomy may be recommended for a number of conditions. For some of these conditions, there may be an alternative to hysterectomy, described below. (See 'Alternatives to hysterectomy' below.) Abnormal uterine bleeding  — Excessive uterine bleeding, called menorrhagia, can lead to anemia (low blood iron count), fatigue, and contribute to missed days at work or school. Menorrhagia is generally defined as bleeding that lasts longer than seven days or saturates more than one pad per hour for several hours. Abnormal uterine bleeding (or any uterine bleeding after menopause) can also be a sign of uterine cancer. All women with these symptoms should undergo evaluation. Heavy or irregular bleeding are generally treated first with medication or other surgical alternatives to hysterectomy. (See "Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics)" .) However, abnormal uterine bleeding that does not improve with conservative treatments may require hysterectomy. Fibroids  — Fibroids (also known as leiomyoma) are noncancerous growths of uterine muscle that occur in up to one-third of all women. Fibroids may become larger during pregnancy, and typically shrink after menopause. They may cause excessive bleeding and pelvic pain or pressure. (See "Patient information: Uterine fibroids (Beyond the Basics)" .)

Fibroids  — Fibroids (also known as leiomyoma) are noncancerous growths of uterine muscle that occur in up to one-third of all women. Fibroids may become larger during pregnancy, and typically shrink after menopause. They may cause excessive bleeding and pelvic pain or pressure. (See "Patient information: Uterine fibroids (Beyond the Basics)" .) Pelvic organ prolapse  — Pelvic organ prolapse occurs due to stretching and weakening of the pelvic muscles and ligaments. This allows the uterus to fall (or prolapse) into the vagina. Prolapse is more common in women who have been pregnant, had vaginal childbirth, and in those with certain genetic factors, lifestyle factors (repeated heavy lifting over the lifetime), or chronic constipation. Cervical abnormalities  — Hysterectomy is rarely needed for severe cervical precancer that does not resolve after other procedures (such as cone biopsy). (See "Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)" and "Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)" .) Endometrial hyperplasia  — Endometrial hyperplasia is the term used to describe excessive growth of the endometrium (the tissue that lines the uterus). It can sometimes lead to endometrial cancer. Although endometrial hyperplasia can often be treated with medication, a hysterectomy is sometimes needed or preferred to medical therapy. Cancer  — Cancer of the uterus (endometrium), cervix, or ovaries may require hysterectomy. (See "Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)" and "Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)" and "Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)" .) Severe bleeding after childbirth  — Hysterectomy may rarely be required in women who have uncontrollable bleeding after childbirth.

Cancer  — Cancer of the uterus (endometrium), cervix, or ovaries may require hysterectomy. (See "Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)" and "Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)" and "Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)" .) Severe bleeding after childbirth  — Hysterectomy may rarely be required in women who have uncontrollable bleeding after childbirth. Chronic pelvic pain  — Chronic pelvic pain can be due to the effects of endometriosis or scarring (adhesions) in the pelvis and between pelvic organs. However, pelvic pain can also be caused by other sources, including the gastrointestinal and urinary systems. (See "Patient information: Chronic pelvic pain in women (Beyond the Basics)" .) It is important for a woman with pelvic pain to ask about the probability that her pain will improve after hysterectomy. PRE-OPERATIVE PLANNING AND EVALUATION Before surgery, there are two main decisions that need to be made about the procedure: whether the cervix should be removed and whether the ovaries and tubes should be removed. If the ovaries are removed, a woman may need to decide if she should take estrogen replacement therapy. Supracervical/subtotal hysterectomy  — A standard abdominal hysterectomy includes removal of the entire uterus and cervix. However, there are situations in which the entire uterus is not removed. A supracervical, subtotal, or partial hysterectomy refers to a procedure in which the cervix is left in place, while the top of the uterus is removed. Supracervical hysterectomy may be done if difficulties arise during surgery, making removal of the cervix complicated. Prior to planned supracervical hysterectomy, you should discuss the risks and benefits of leaving the cervix in place with your doctor. Women who undergo supracervical hysterectomy must continue to have routine screening (Pap smear) for cervical cancer. Some women continue to have menstrual bleeding since the retained cervix is attached to a small remaining portion of the uterus. There was initial concern that removing the cervix would interfere with sexual satisfaction. However, studies have demonstrated that sexual satisfaction does not appear to differ after hysterectomy between women with and without a cervix.

Women who undergo supracervical hysterectomy must continue to have routine screening (Pap smear) for cervical cancer. Some women continue to have menstrual bleeding since the retained cervix is attached to a small remaining portion of the uterus. There was initial concern that removing the cervix would interfere with sexual satisfaction. However, studies have demonstrated that sexual satisfaction does not appear to differ after hysterectomy between women with and without a cervix. Removal of ovaries  — The ovaries may be removed during hysterectomy, a procedure known as an oophorectomy. Oophorectomy is not always required; the decision depends upon several considerations. Premenopausal women may decide to keep the ovaries to provide a continued, natural source of hormones, including estrogen, progesterone, and testosterone. These hormones are important in maintaining sexual interest and preventing hot flashes and loss of bone density loss. On the other hand, women who have menstrual cycle-related migraines, epilepsy, or severe premenstrual syndrome (PMS) may have an improvement in symptoms when hormone levels are reduced by removing the ovaries. Discuss the risks and preferences of removing the ovaries with your doctor before surgery. Postmenopausal women are often advised to have their ovaries removed because of a small risk of developing ovarian cancer at some point during their lifetime. The benefits of removing or keeping ovaries should be discussed with a physician. Estrogen therapy  — Estrogen therapy (ET) may be recommended after surgery for women who have not reached menopause who had their ovaries removed. ET can help to prevent hot flashes, night sweats, and loss of bone density, which may occur when the ovaries are surgically removed. Women who plan to use ET should talk with their clinician about the risks and benefits, and about how long to use this treatment. (See "Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)" .) Women who have completed menopause generally do not require ET after hysterectomy. (See "Patient information: Postmenopausal hormone therapy (Beyond the Basics)" .) Pre-operative testing  — Standard pre-operative testing may include a physical examination, EKG, chest x-ray, and blood testing, depending upon age and other medical conditions. ABDOMINAL HYSTERECTOMY PROCEDURE

Women who have completed menopause generally do not require ET after hysterectomy. (See "Patient information: Postmenopausal hormone therapy (Beyond the Basics)" .) Pre-operative testing  — Standard pre-operative testing may include a physical examination, EKG, chest x-ray, and blood testing, depending upon age and other medical conditions. ABDOMINAL HYSTERECTOMY PROCEDURE Abdominal hysterectomy is performed in a hospital setting, and generally requires approximately two hours in the operating room. Patients are given general or spinal anesthesia plus sedation so that they feel no pain. Heart rate, blood pressure, blood loss, and respiration are closely observed throughout the procedure. After surgery, patients are transferred to the recovery room (also known as the post-anesthesia care unit) so that they can be monitored while waking up. Most patients will then be transferred to a hospital room, where they will spend one to two nights. ABDOMINAL HYSTERECTOMY COMPLICATIONS A number of complications can occur as a result of hysterectomy. Fortunately, most can be easily managed and do not cause long-term problems. Hemorrhage  — Excessive bleeding (hemorrhage) occurs in a small number of cases and may require a return to the operating room to identify and stop the bleeding. Infection  — Low-grade fever is common after hysterectomy, is not always caused by infection, and usually resolves without treatment. However, a high or persistent fever may signal an infection. Serious infection occurs in less than ten percent of women, and can usually be treated with intravenous antibiotics. Much less commonly, patients require another surgical procedure. Constipation  — Constipation occurs in most women following hysterectomy, and can usually be controlled with a regimen of stool softeners, dietary fiber, and laxatives. Urinary retention  — Urinary retention, or the inability to pass urine, can occur after abdominal hysterectomy. It is more common in women who have vaginal hysterectomy. (See 'Alternatives to hysterectomy' below.) Urine can be drained using a catheter until retention resolves, usually within 24 to 48 hours.

Constipation  — Constipation occurs in most women following hysterectomy, and can usually be controlled with a regimen of stool softeners, dietary fiber, and laxatives. Urinary retention  — Urinary retention, or the inability to pass urine, can occur after abdominal hysterectomy. It is more common in women who have vaginal hysterectomy. (See 'Alternatives to hysterectomy' below.) Urine can be drained using a catheter until retention resolves, usually within 24 to 48 hours. Blood clots  — Pelvic surgery increases the risk of developing blood clots in the large veins of the leg or lung. The risk is increased for approximately six weeks after surgery. Medications may be given to some women to prevent blood clots. In addition, women taking oral contraceptives or hormone replacement should ideally discontinue them prior to surgery since they can further increase the risk of blood clots. Women who are sexually active and premenopausal should use alternative methods of birth control (e.g. condoms) to prevent pregnancy before surgery. (See "Patient information: Deep vein thrombosis (DVT) (Beyond the Basics)" .) Damage to adjacent organs  — The urinary bladder, ureters (small tubes leading from the kidneys to the bladder), and large and small intestines are located in the lower abdomen and pelvis and can be injured during hysterectomy. Injury occurs in less than one percent of all women undergoing hysterectomy, and can usually be detected and corrected at the time of surgery. If detected after surgery, another operation may be needed. Early menopause  — Women who have undergone hysterectomy may experience menopause earlier than the average age of menopause (age 51). This may be due to an interruption in blood flow to the ovaries as a result of removing the uterus. RECOVERY AFTER ABDOMINAL HYSTERECTOMY Fluids and food are generally offered soon after surgery. Intravenous (IV) fluids may be administered during the first day, particularly if there is nausea or vomiting. Pain medicine is given as needed, either intravenously, or by intramuscular (IM) injection, or as a pill. Patients are encouraged to resume their normal daily activities as soon as possible. Being active is particularly important since it helps to prevent complications, such as blood clots, pneumonia, and gas pains.

Fluids and food are generally offered soon after surgery. Intravenous (IV) fluids may be administered during the first day, particularly if there is nausea or vomiting. Pain medicine is given as needed, either intravenously, or by intramuscular (IM) injection, or as a pill. Patients are encouraged to resume their normal daily activities as soon as possible. Being active is particularly important since it helps to prevent complications, such as blood clots, pneumonia, and gas pains. More information about recovery from hysterectomy is available separately. (See "Patient information: Care after gynecologic surgery (Beyond the Basics)" .) LIFE AFTER ABDOMINAL HYSTERECTOMY Studies of women's response to hysterectomy show that most women are satisfied with their results ( table 1 ). Most reported improvement in symptoms, such as pain and vaginal bleeding. Sexual function and enjoyment, interest in sex, and pain with sex were improved for most women. However, this improvement may depend upon several factors, including the age of a woman at the time of surgery, the reason for surgery, and history of any prior difficulties with mood. Younger women may grieve after hysterectomy due to their loss of fertility. A woman who has new feelings of sadness, anxiety, or depression after surgery should speak with her healthcare provider. These feelings may be treated by talking with a therapist, with antidepressant medication, or may resolve with time. (See "Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics)" .) ALTERNATIVES TO HYSTERECTOMY Women who wish to avoid or postpone hysterectomy may be able to use medications or less invasive surgical procedures. Medical and surgical alternatives to hysterectomy depend upon the underlying disorder. The decision as to which treatment is "best" should be based upon a woman's particular medical problem, all available treatment options, and the risks and benefits of each type of treatment. Some alternatives to abdominal hysterectomy include the following:

Women who wish to avoid or postpone hysterectomy may be able to use medications or less invasive surgical procedures. Medical and surgical alternatives to hysterectomy depend upon the underlying disorder. The decision as to which treatment is "best" should be based upon a woman's particular medical problem, all available treatment options, and the risks and benefits of each type of treatment. Some alternatives to abdominal hysterectomy include the following: In some cases the uterus may be removed through the vagina, avoiding the need for an incision in the abdomen. This procedure is called a vaginal hysterectomy. (See "Patient information: Vaginal hysterectomy (Beyond the Basics)" .) A vaginal approach may be used if the uterus is not too big, there is not too much scar tissue, and if the condition prompting the surgery is benign and limited to the uterus. Most women can return to normal activities sooner after a vaginal hysterectomy than after an abdominal hysterectomy. Uterine artery embolization and myomectomy may be used to treat symptomatic leiomyoma (fibroids). (See "Patient information: Uterine fibroids (Beyond the Basics)" .) Pain clinics may be able to treat patients with severe and chronic pelvic pain without surgery. (See "Patient information: Chronic pelvic pain in women (Beyond the Basics)" .) Endometrial ablation, in which a physician destroys or removes most of the endometrium using an instrument inserted through the vagina and cervix and into the uterus. (See "Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics)" .) Medical therapy using hormonal medications, such GnRH analogs (for example, leuprolide) or progestins can help reduce the pain associated with endometriosis. (See "Patient information: Endometriosis (Beyond the Basics)" .) Cone biopsy (eg, cold knife cone), cryosurgery, laser surgery, or loop electrocautery (eg, LEEP or LLETZ) are usually used to treat women with cervical dysplasia (an abnormal Pap smear). These procedures remove the abnormal part of the cervix rather than the entire cervix and uterus (see "Patient information: Cervical cancer screening (Beyond the Basics)" ). WHERE TO GET MORE INFORMATION Your healthcare provider is the best source of information for questions and concerns related to your medical problem.

Cone biopsy (eg, cold knife cone), cryosurgery, laser surgery, or loop electrocautery (eg, LEEP or LLETZ) are usually used to treat women with cervical dysplasia (an abnormal Pap smear). These procedures remove the abnormal part of the cervix rather than the entire cervix and uterus (see "Patient information: Cervical cancer screening (Beyond the Basics)" ). WHERE TO GET MORE INFORMATION Your healthcare provider is the best source of information for questions and concerns related to your medical problem. This article will be updated as needed on our web site ( www.uptodate.com/patients ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below. Patient level information  — UpToDate offers two types of patient education materials. The Basics  — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Patient information: Hysterectomy (The Basics) Patient information: Ovarian cancer (The Basics) Patient information: Uterine cancer (The Basics) Patient information: Endometriosis (The Basics) Patient information: Postpartum hemorrhage (The Basics) Patient information: Preserving fertility after cancer treatment in women (The Basics) Patient information: Uterine adenomyosis (The Basics) Beyond the Basics  — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.

Patient information: Hysterectomy (The Basics) Patient information: Ovarian cancer (The Basics) Patient information: Uterine cancer (The Basics) Patient information: Endometriosis (The Basics) Patient information: Postpartum hemorrhage (The Basics) Patient information: Preserving fertility after cancer treatment in women (The Basics) Patient information: Uterine adenomyosis (The Basics) Beyond the Basics  — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon. Patient information: Menorrhagia (excessive menstrual bleeding) (Beyond the Basics) Patient information: Uterine fibroids (Beyond the Basics) Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics) Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics) Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics) Patient information: Endometrial cancer treatment after surgery (Beyond the Basics) Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics) Patient information: Chronic pelvic pain in women (Beyond the Basics) Patient information: Early menopause (primary ovarian insufficiency) (Beyond the Basics) Patient information: Postmenopausal hormone therapy (Beyond the Basics) Patient information: Deep vein thrombosis (DVT) (Beyond the Basics) Patient information: Care after gynecologic surgery (Beyond the Basics) Patient information: Vaginal hysterectomy (Beyond the Basics) Patient information: Endometriosis (Beyond the Basics) Patient information: Cervical cancer screening (Beyond the Basics) Professional level information  — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.

Professional level information  — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading. Abdominal hysterectomy An overview of endometrial ablation Dilation and curettage Hysteroscopic myomectomy Laparoscopic approach to hysterectomy Prolapsed uterine leiomyoma (fibroid) Overview of hysterectomy Overview of hysteroscopy Peripartum hysterectomy Radical hysterectomy Vaginal hysterectomy Abdominal myomectomy The following organizations also provide reliable health information. National Library of Medicine ( www.nlm.nih.gov/medlineplus/healthtopics.html ) The American College of Obstetricians and Gynecologists ( www.acog.org ) US Department of Health & Human Services, Federal Government Source for Women's Health Information ( womenshealth.gov ) [ 1-4 ] Literature review current through: Oct 2013. | This topic last updated: Mar 21, 2012. Find Print The content on the UpToDate website is not intended nor recommended as a substitutefor medical advice, diagnosis, or treatment. Always seek the advice of your own physician orother qualified health care professional regarding any medical questions or conditions. Theuse of this website is governed by the UpToDate Terms of Use ©2013 UpToDate, Inc. References Top Meeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol 1997; 40:886. Harris WJ. Complications of hysterectomy. Clin Obstet Gynecol 1997; 40:928. Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol 1994; 83:556. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999; 282:1934.

REFERENCES Committee on Practice Bulletins--Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007; 110:429. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e227S. Larsson PG, Carlsson B. Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis? Infect Dis Obstet Gynecol 2002; 10:133. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 74. Antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2006; 108:225. Hernandez CR, Howard FM. Management of tubal prolapse after hysterectomy. J Am Assoc Gynecol Laparosc 1998; 5:59. Petrakis IE, Lasithiotakis KG, Chalkiadakis GE. Use of the LigaSure vessel sealer in total abdominal hysterectomy. Int J Gynaecol Obstet 2005; 89:303. Lakeman M, Kruitwagen RF, Vos MC, Roovers JP. Electrosurgical bipolar vessel sealing versus conventional clamping and suturing for total abdominal hysterectomy: a randomized trial. J Minim Invasive Gynecol 2008; 15:547. Hagen B, Eriksson N, Sundset M. Randomised controlled trial of LigaSure versus conventional suture ligature for abdominal hysterectomy. BJOG 2005; 112:968. Kilkku P, Grönroos M, Rauramo L. Supravaginal uterine amputation with peroperative electrocoagulation of endocervical mucosa. Description of the method. Acta Obstet Gynecol Scand 1985; 64:175. Kaya H, Sezik M, Ozbasar D, et al. Intrafascial versus extrafascial abdominal hysterectomy: effects on urinary urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:171. Colombo M, Maggioni A, Zanini A, et al. A randomized trial of open versus closed vaginal vault in the prevention of postoperative morbidity after abdominal hysterectomy. Am J Obstet Gynecol 1995; 173:1807. Aharoni A, Kaner E, Levitan Z, et al. Prospective randomized comparison between an open and closed vaginal cuff in abdominal hysterectomy. Int J Gynaecol Obstet 1998; 63:29. Berman ML, Grosen EA. A new method of continuous vaginal cuff closure at abdominal hysterectomy. Obstet Gynecol 1994; 84:478.

Colombo M, Maggioni A, Zanini A, et al. A randomized trial of open versus closed vaginal vault in the prevention of postoperative morbidity after abdominal hysterectomy. Am J Obstet Gynecol 1995; 173:1807. Aharoni A, Kaner E, Levitan Z, et al. Prospective randomized comparison between an open and closed vaginal cuff in abdominal hysterectomy. Int J Gynaecol Obstet 1998; 63:29. Berman ML, Grosen EA. A new method of continuous vaginal cuff closure at abdominal hysterectomy. Obstet Gynecol 1994; 84:478. Neuman M, Beller U, Ben Chetrit A, et al. Prophylactic effect of the open vaginal vault method in reducing febrile morbidity in abdominal hysterectomy. Surg Gynecol Obstet 1993; 176:591. Jaszczak SE, Evans TN. Intrafascial abdominal and vaginal hysterectomy: a reappraisal. Obstet Gynecol 1982; 59:435. Wall LL. A technique for modified McCall culdeplasty at the time of abdominal hysterectomy. J Am Coll Surg 1994; 178:507. Thakar R, Sultan AH. Hysterectomy and pelvic organ dysfunction. Best Pract Res Clin Obstet Gynaecol 2005; 19:403. Jenkins TR. It's time to challenge surgical dogma with evidence-based data. Am J Obstet Gynecol 2003; 189:423. Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007; 105:801. Okin CR, Guido RS, Meyn LA, Ramanathan S. Vasopressin during abdominal hysterectomy: a randomized controlled trial. Obstet Gynecol 2001; 97:867. Unger JB, Paul R, Caldito G. Hysterectomy for the massive leiomyomatous uterus. Obstet Gynecol 2002; 100:1271. De Lia JE, Michelin DP, Johnson SC, Kajdacsy-Balla A. Cherney versus midline vertical incision for myomectomy or hysterectomy of a significantly enlarged uterus. Am J Obstet Gynecol 1995; 173:1714. Falcone T, Walters MD. Hysterectomy for benign disease. Obstet Gynecol 2008; 111:753. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; :CD000547. Maresh MJ, Metcalfe MA, McPherson K, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG 2002; 109:302.

Falcone T, Walters MD. Hysterectomy for benign disease. Obstet Gynecol 2008; 111:753. Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; :CD000547. Maresh MJ, Metcalfe MA, McPherson K, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG 2002; 109:302. Garry R, Fountain J, Mason S, et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004; 328:129. Cole P, Berlin J. Elective hysterectomy. Am J Obstet Gynecol 1977; 129:117. Meeks GR, Harris RL. Surgical approach to hysterectomy: abdominal, laparoscopy-assisted, or vaginal. Clin Obstet Gynecol 1997; 40:886. Thakar R, Ayers S, Clarkson P, et al. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 2002; 347:1318. Mäkinen J, Johansson J, Tomás C, et al. Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod 2001; 16:1473. Lethaby A, Ivanova V, Johnson NP. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev 2006; :CD004993. Hemsell DL. Infections after gynecologic surgery. Obstet Gynecol Clin North Am 1989; 16:381. Bartzen PJ, Hafferty FW. Pelvic laparotomy without an indwelling catheter. A retrospective review of 949 cases. Am J Obstet Gynecol 1987; 156:1426. Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillieres Clin Obstet Gynaecol 1997; 11:403. Härkki-Sirén P, Sjöberg J, Tiitinen A. Urinary tract injuries after hysterectomy. Obstet Gynecol 1998; 92:113. Ibeanu OA, Chesson RR, Echols KT, et al. Urinary tract injury during hysterectomy based on universal cystoscopy. Obstet Gynecol 2009; 113:6. Al-Sunaidi M, Tulandi T. Adhesion-related bowel obstruction after hysterectomy for benign conditions. Obstet Gynecol 2006; 108:1162. Hur HC, Guido RS, Mansuria SM, et al. Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies. J Minim Invasive Gynecol 2007; 14:311. Croak AJ, Gebhart JB, Klingele CJ, et al. Characteristics of patients with vaginal rupture and evisceration. Obstet Gynecol 2004; 103:572.

Al-Sunaidi M, Tulandi T. Adhesion-related bowel obstruction after hysterectomy for benign conditions. Obstet Gynecol 2006; 108:1162. Hur HC, Guido RS, Mansuria SM, et al. Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies. J Minim Invasive Gynecol 2007; 14:311. Croak AJ, Gebhart JB, Klingele CJ, et al. Characteristics of patients with vaginal rupture and evisceration. Obstet Gynecol 2004; 103:572. Iversen L, Hannaford PC, Elliott AM, Lee AJ. Long term effects of hysterectomy on mortality: nested cohort study. BMJ 2005; 330:1482. Wingo PA, Huezo CM, Rubin GL, et al. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985; 152:803. Wu JM, Wechter ME, Geller EJ, et al. Hysterectomy rates in the United States, 2003. Obstet Gynecol 2007; 110:1091. Phipps S, Lim YN, McClinton S, et al. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev 2006; :CD004374. Charoenkwan K, Phillipson G, Vutyavanich T. Early versus delayed (traditional) oral fluids and food for reducing complications after major abdominal gynaecologic surgery. Cochrane Database Syst Rev 2007; :CD004508. Iaco PD, Ceccaroni M, Alboni C, et al. Transvaginal evisceration after hysterectomy: is vaginal cuff closure associated with a reduced risk? Eur J Obstet Gynecol Reprod Biol 2006; 125:134. Topic 3311 Version 16.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]